HBK Investments’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,316
Closed -$468K 364
2023
Q2
$468K Buy
+5,316
New +$458K ﹤0.01% 339
2020
Q1
Sell
-4,060
Closed -$461K 321
2019
Q4
$461K Sell
4,060
-102,555
-96% -$11.3M ﹤0.01% 581
2019
Q3
$11.6M Buy
106,615
+67,194
+170% +$7.01M 0.15% 98
2019
Q2
$3.84M Buy
39,421
+18,300
+87% +$1.67M 0.03% 273
2019
Q1
$1.92M Sell
21,121
-123,535
-85% -$11.1M 0.02% 532
2018
Q4
$13.2M Buy
+144,656
New +$13.5M 0.14% 111
2018
Q3
Sell
-43,539
Closed -$3.73M 1282
2018
Q2
$3.73M Sell
43,539
-8,811
-17% -$736K 0.02% 330
2018
Q1
$4.2M Buy
52,350
+24,055
+85% +$1.98M 0.03% 308
2017
Q4
$2.29M Buy
+28,295
New +$2.27M 0.02% 416
2014
Q4
Sell
-263,028
Closed -$16.3M 1070
2014
Q3
$16.3M Buy
+263,028
New +$16.7M 0.25% 68

Other funds holding MDT

HBK Investments's MDT Position: Q3 2023 in Review

HBK Investments sold out of Medtronic (MDT) in Q3 2023, closing a stake of 5,316 shares — an estimated $468K sold.

HBK Investments first reported a position in MDT in Q3 2014 and held it in 10 quarters. The position peaked at $16.3M in Q3 2014. 1,970 funds tracked by Wall St. Rank hold MDT as of Q3 2023.

  • HBK Investments reported no remaining Medtronic position as of Q3 2023 after selling out during the quarter.
  • HBK Investments sold 5,316 Medtronic shares in Q3 2023, an estimated $468K.
  • HBK Investments first reported a position in Medtronic in Q3 2014 and held it in 10 quarters.
  • HBK Investments's Medtronic position peaked at $16.3M in Q3 2014.
  • 1,970 funds tracked by Wall St. Rank held Medtronic as of Q3 2023.

Based on HBK Investments's 13F filing for Q3 2023, filed 14 Nov 2023.